MedTrace Logo

Ventricular Pacing Site Selection (V-PASS)

NCT00292383 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2011-08-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether there is a relationship between ventricular lead position and the incidence of heart failure and atrial fibrillation in patients with indication for permanent pacemaker stimulation.

Conditions

  • Atrioventricular Block

Interventions

PROCEDURE

Leads to be implanted according randomization on specified sites. Vitatron pacemakers to be implanted: T60 DR, T70 DR, T20 SR, C60 DR

Sponsors & Collaborators

  • Vitatron GmbH

    collaborator INDUSTRY

  • Medtronic BRC

    lead INDUSTRY

Principal Investigators

  • Jochem F. Stockinger, MD · Herzzentrum Bad Krozingen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Completion
2008-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00292383 on ClinicalTrials.gov